AI Cytology and Digital Pathology
Solutions
Founded in 2000, Landing Med is a medtech company focused on early
cancer detection solutions. We offer affordableAI-powered cytology and
digital pathology technologies to empower laboratories worldwide to
enhance diagnostic precision, efficiency, and confidence. As a globally
recognized leader in cervical cytology screening, we have successfully
screened over 10 million women and strive to make pathology accessible
to all.
Read More
____________
Our Products
____________
Global Publications
____________
Testimonials
____________
In the Press
____________
Landing Med Certifications
____________
Our Partners
Portable Digital Pathology
Slide Scanner
LD Patho 320
High Throughput Digital Pathology Slide Scanner
LD Cyto2200
Al Cervical Cytology Screening System
Al Cervical
2023, The Lancet Regional
Health-Western Pacific
Cost-effectiveness of artificial intelligenceassisted liquid-based cytology testingfor
cervical cancer screening in China
Read More
2021, Cervical Cancer
Role of Al in Cervical Cancer Screening
The artificial intelligence-assisted cytology
diagnostic system in large-scale cervical cancer
screening: A population-based cohort study of
0.7 million women
2020, Cancer Medicine
See all Global Publications >
Landing Med, a Chinese medtech company focused on early cancer detection, has achieved a significant milestone by completing over 10 million cervical cancer screenings using artificial intelligence...
2024-05-10
____________
Contact us
Address:
B7 Medical Device Park, 818 Gaoxin Road East Lake High-Tech Zone,
Wuhan, Hubei Province, China
Contact Us:
hello@landing-med.co
LinkedIn:
Landing Med
Let's get in touch
Quick menu
B7 Medical Device Park,
818 Gaoxin Road East Lake High-Tech ZoneWuhan, Hubei Province, China
hello@landing-med.comb
|
|